Interaction of solid-phase gangliosides with tetanus toxin and toxoidHABERMANN, E; TAYOT, J. L.Toxicon (Oxford). 1985, Vol 23, Num 6, pp 913-920, issn 0041-0101Article

Modulation of cellular phorbol ester binding and/or protein kinase C activity by human placental fractionsHAMEL, E; TAYOT, J.-L; YAMASAKI, H et al.Biochimica et biophysica acta. 1988, Vol 970, Num 2, pp 172-176, issn 0006-3002Article

Affinity chromatographic purification and characterization of two iodinated tetanus toxin fractions exhibiting different binding propertiesLAZAROVICI, P; TAYOT, J. L; YAVIN, E et al.Toxicon (Oxford). 1984, Vol 22, Num 3, pp 401-413, issn 0041-0101Article

Isolation and characterization of two different molecular forms of basic fibroblast growth factor extracted from human placental tissueUHLRICH, S; TIOLLIER, J; TARDY, M et al.Journal of chromatography. 1991, Vol 539, Num 2, pp 393-403, issn 0021-9673, 11 p.Conference Paper

Towards large-scale purification of natural CSF-1 from human placenta tissue extractsMARTIN-THOUVENIN, V; UHLRICH, S; TAYOT, J. L et al.Biotechnology and applied biochemistry. 1990, Vol 12, Num 2, pp 176-187, issn 0885-4513Article

Fibroblast behavior on gels of type I, III, and IV human placental collagensTIOLLIER, J; DUMAS, H; TARDY, M et al.Experimental cell research. 1990, Vol 191, Num 1, pp 95-104, issn 0014-4827, 10 p.Article

Le tissu placentaire humain: une source de régulateurs hématopoiétiques naturels = Human placental tissue extracts. A source of natural haemopoietic regulatorsMARTIN-THOUVENIN, V; N'GUYEN, C; TAYOT, J.-L et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1987, Vol 305, Num 12, pp 459-464, issn 0764-4469Article

Prilling process applied to collagen solutionsDUMAS, H; TARDY, M; ROCHAT, M. H et al.Drug development and industrial pharmacy. 1992, Vol 18, Num 13, pp 1395-1409, issn 0363-9045Article

Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cells = Caractérisation d'un facteur placentaire humain qui inhibe la fixation spécifique des phorbol esters aux cellules en cultureHAMEL, E; MARTEL, N; TAYOT, J. L et al.Carcinogenesis (New York. Print). 1984, Vol 5, Num 1, pp 15-21, issn 0143-3334Article

Growth suppression of transformed cells by a human placental extract not related to transforming growth factor βKLEIN, J. L; HAMEL, E; TAYOT, J. L et al.Journal of cancer research and clinical oncology. 1991, Vol 117, Num 3, pp 192-196, issn 0171-5216, 5 p.Article

Retroconversion and metabolism of [¹³C]22:6n-3 in humans and rats after intake of a single dose of [¹³C]22:6n-3-triacylglycerolsBROSSARD, N; CROSET, M; PACHIAUDI, C et al.The American journal of clinical nutrition. 1996, Vol 64, Num 4, pp 577-586, issn 0002-9165Article

Phospholipid molecular species from human placenta lipidsBAYON, Y; CROSET, M; CHIROUZE, V et al.Lipids. 1993, Vol 28, Num 7, pp 631-636, issn 0024-4201Article

Utilisation du collagène de type IV réticulé humain placentaire dans les tympanoplasties : résultats de l'expérimentation préliminaire animale = Use of human type IV collagen film in tympanoplasty. Results of preliminary experimentation in the dogTRUY, E; DISANT, F; TARDY, M et al.Annales d'oto-laryngologie et de chirurgie cervico-faciale. 1990, Vol 107, Num 3, pp 209-213, issn 0003-438X, 5 p.Article

Kératophakie avec des lentilles en collagène IV chez le primate non humain = Keratopathy with collagen IV lens in non human primatesTRODE, M; ROMANET, J. P; MOUILLON, M et al.Ophtalmologie (Paris). 1994, Vol 8, Num 2, pp 167-168, issn 0989-3105Article

Epikératoplastie sans suture avec lentille de collagéne IV chez le singe : description de la technique chirurgicale = Epikeratoplasty technique without suture using human collagen type IV lenticules: experimental study on monkeyALBINET, P; ROMANET, J. P; MOUILLON, M et al.Journal français d'ophtalmologie. 1990, Vol 13, Num 3, pp 109-114, issn 0181-5512, 6 p.Article

Le collagène IV visqueux d'origine humaine: propriétés physiques et tolérance expérimentale = Viscous human collagen IV: physical proprieties and experimental toleranceCHARLEUX, J; CHARLEUX, M; DUPONT, D et al.Ophtalmologie. 1989, Vol 3, Num 4, pp 308-311Conference Paper

Metabolic fate of an oral tracer dose of [¹³C]docosahexaenoic acid triglycerides in the ratBROSSARD, N; CROSET, M; LECERF, J et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1996, Vol 39, Num 4, pp R846-R854, issn 0363-6119Article

Utilisation du collagène humain type (IV) en chirurgie cornéenne réfractive: étude expérimentale = Human collagen (type IV) in refractive corneal surgeryROMANET, J. P; ALBINET, P; MOUILLON, M et al.Ophtalmologie. 1988, Vol 2, Num 4, pp 285-289Conference Paper